Research
UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation
CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly.
April 14, 2026
Health
At the Bedside: First baby to receive novel spina bifida surgery at UTHealth Houston thriving 6 months after treatment
March 04, 2026
Research
UTHealth Houston researchers awarded $1.3M to develop a conversational AI platform for patient care
April 17, 2026
New UTHealth Houston center will focus on congenital heart disease breakthroughs
April 14, 2026
Education
Ask the Expert: What families should know about electric scooters
As e-scooters rise in popularity and more kids are outdoors this spring and summer, here’s what families, kids, and the public should know about scooter safety.
April 08, 2026
